Extendicare Stock Beta
| EXETFDelisted Stock | USD 5.00 0.00 0.00% |
Extendicare fundamentals help investors to digest information that contributes to Extendicare's financial success or failures. It also enables traders to predict the movement of Extendicare Pink Sheet. The fundamental analysis module provides a way to measure Extendicare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Extendicare pink sheet.
Extendicare |
Extendicare Company Beta Analysis
Extendicare's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Extendicare Beta | 1.2 |
Most of Extendicare's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Extendicare is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
CompetitionIn accordance with the recently published financial statements, Extendicare has a Beta of 1.1994. This is 39.47% higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The beta for all United States stocks is notably lower than that of the firm.
Extendicare Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Extendicare's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Extendicare could also be used in its relative valuation, which is a method of valuing Extendicare by comparing valuation metrics of similar companies.Extendicare is currently under evaluation in beta category among its peers.
As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Extendicare will likely underperform.
Extendicare Fundamentals
| Return On Equity | 0.0018 | ||||
| Return On Asset | 0.11 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.12 % | ||||
| Current Valuation | 556.43 M | ||||
| Shares Outstanding | 83.94 M | ||||
| Shares Owned By Insiders | 13.15 % | ||||
| Shares Owned By Institutions | 17.61 % | ||||
| Price To Earning | 500.00 X | ||||
| Price To Book | 4.28 X | ||||
| Price To Sales | 0.32 X | ||||
| Revenue | 1.22 B | ||||
| Gross Profit | 283.88 M | ||||
| EBITDA | 79.64 M | ||||
| Net Income | 11.5 M | ||||
| Cash And Equivalents | 174.61 M | ||||
| Cash Per Share | 2.08 X | ||||
| Total Debt | 463.27 M | ||||
| Debt To Equity | 2.85 % | ||||
| Current Ratio | 1.09 X | ||||
| Book Value Per Share | 1.49 X | ||||
| Cash Flow From Operations | 63.42 M | ||||
| Earnings Per Share | 0.01 X | ||||
| Number Of Employees | 31 | ||||
| Beta | 1.2 | ||||
| Market Capitalization | 419.69 M | ||||
| Total Asset | 900.32 M | ||||
| Z Score | 1.0 | ||||
| Annual Yield | 0.07 % | ||||
| Five Year Return | 6.60 % | ||||
| Net Asset | 900.32 M | ||||
| Last Dividend Paid | 0.48 |
About Extendicare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Extendicare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Extendicare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Extendicare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Consideration for investing in Extendicare Pink Sheet
If you are still planning to invest in Extendicare check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Extendicare's history and understand the potential risks before investing.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |